The soluble form of TREM-1 is released into human bloods in certain diseases, such as sepsis [17], RA [18], pneumonia [19], and primary antiphospholipid [20], and can thus serve as a biomarker for these diseases. Here, TREM1 is linked to rheumatoid arthritis.